Established in 2005, Modavar Pharmaceuticals is a Washington, D.C.-headquartered subsidiary of India’s Cadila Pharmaceuticals and a specialty pharmaceutical company. Its FDA-approved Frederick, Maryland facility gives the company a U.S. base for developing and manufacturing topical products, while its broader work supports pharmaceutical partners serving the U.S. and European markets.
U.S. FDA Approved
compliance_program
cGMP-Compliant Manufacturing Services
compliance_program
WHO Geneva Approval
compliance_program
UK MHRA Approval
compliance_program
TGA Australia Approval
compliance_program
MCC South Africa Approval
compliance_program
ANVISA Brazil Approval
compliance_program
OSHA Policies
compliance_program